GSK690693 ≥95%

Supplier: ADIPOGEN CORP MS
Danger

Synonyms: (S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol, GSK-690693

AG-CR1-3628-M005 AG-CR1-3628-M025
102987-440EA 131.54 USD
102987-440 102987-442
GSK690693 ≥95%
GSK690693

pan-Akt inhibitor targeting Akt1, 2, 3 with IC50 values of 2, 13 and 9 nM, respectively. Inhibits AMPK, DAPK3, PAK4, 5 and 6, as well as members of the AGC kinase family including PKA, PrkX and PKC isoforms (IC50 100 nM). Occupies the ATP binding pocket of the kinase domain and competes with ATP. Anti-cancer compound both in vitro and in vivo. Blocks the phosphorylation of downstream targets of ATK in a dose-dependent manner, which leads to antiproliferative and apoptotic effects in tumor cell lines. Induces hyperglycemia related to peripheral insulin resistance, increased gluconeogenesis, and/or hepatic glycogenolysis.

Formula: C₂₁H₂₇N₇O₃
MW: 425.5 g/mol
Storage Temperature: Freezer
MDL Number: MFCD14105605
CAS Number: 937174-76-0
UN: 2811
ADR: 6.1,III

Order Now

Specification Test Results

Purity 95%
Appearance/Color Off-white to pale yellow solid.
Solubility Soluble in DMSO. Slightly soluble (1mg/ml) in ethanol.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR